NSE மற்றும் BSE-யின் ஒவ்வொரு கார்ப்பரேட் அறிவிப்பும், AI-யால் சில நிமிடங்களில் படிக்கப்பட்டு விளக்கப்படுகிறது — தாக்கம், முக்கிய புள்ளிவிவரங்கள், குறுகிய/நீண்டகாலப் பார்வை, கவனிக்க வேண்டியவை.
நேரலைசமீபத்திய அறிவிப்பு: 6 நாட்களுக்கு முன்இன்று 0 பகுப்பாய்வு செய்யப்பட்டது
குறிப்பு: இவை NSE பொது அறிக்கைகளின் AI-உருவாக்கிய, கல்வி நோக்கச் சுருக்கங்கள் — ஒவ்வொரு ஆவணத்தையும் ஆதாரமாகக் கொண்டவை, ஆனால் முதலீட்டு ஆலோசனை அல்ல, மேலும் முழுமையற்றதாகவும் இருக்கலாம். அசல் அறிக்கையுடன் சரிபார்க்கவும், செயல்படுவதற்கு முன் SEBI-பதிவு பெற்ற முதலீட்டு ஆலோசகரை அணுகவும்.
Marico to Acquire 51% Stake in Bonorizon Consumer for Up to ₹35 Cr
Marico has entered into definitive agreements to acquire a 51% equity stake and voting rights in Bonorizon Consumer Ventures Private Limited through primary subscription for an aggregate cash consideration of up to ₹35 crore. Bonorizon, incorporated on October 22, 2026, operates in the FMCG and consumer products space with a wholly owned subsidiary in the US (Bonorizon Consumer Ventures LLC). The deal includes an option for Marico to acquire the remaining 49% stake after three years based on milestone achievements. Relative to Marico's TTM revenue of ₹14,309 crore and cash surplus of ₹2,150 crore, the transaction is financially minor (less than 0.25% of revenue), aiming to seed digital growth in international markets.
உச்சம் நம்பிக்கை
என்ன மாறியதுMarico signed definitive agreements to acquire majority control (51%) of newly-incorporated Bonorizon Consumer Ventures for up to ₹35 crore.
ஏன் இது முக்கியம்Aligns with Marico's strategic thrust to accelerate its digital-first and international FMCG portfolio, though its immediate financial contribution is negligible given the target's start-up stage.
Acquisition cost: up to Rs. 35 CroresEquity stake acquired: 51%Deal size vs TTM revenue: ~0.24%Completion timeline: within 90 daysTarget incorporation date: அக்டோபர் 22, 2026
📅 குறுகிய காலம்Minimal near-term impact on financial performance or stock price given the small deal size (₹35 crore) relative to Marico's market capitalization of ₹120,358 crore.
📈 நீண்ட காலம்Serves as an early-stage incubator for Marico's international digital-first consumer brand footprint, with full buyout potential after three years if milestones are met.
⚠ அபாய எச்சரிக்கைகள்
Early-stage venture risk as the target has no established operating history or track record of turnover
Execution risk in scaling cross-border FMCG operations
👀 கவனிக்க வேண்டியவை
Track the completion of customary closing conditions within the 90-day window and watch for subsequent commentary on Bonorizon's specific product pipeline and geographical rollouts in future quarterly earnings calls.
Marico Acquires Additional 20% Stake in Cosmix Wellness for Rs 113.65 Cr, Raising Stake to 80%
Marico Limited has completed the acquisition of an additional 20% paid-up share capital in its subsidiary Cosmix Wellness Private Limited for a cash consideration of Rs 113.65 crore. With this transaction, Marico's aggregate holding has expanded from 60% to 80%. Cosmix Wellness operates as a digital-first functional wellness brand and reported an annual turnover of Rs 91.53 crore in FY26, with an annualized run-rate (ARR) exceeding Rs 170 crore over the last 3 months. Marico also holds the right to acquire the remaining 20% stake after FY29 subject to milestone achievements.
உச்சம் நம்பிக்கை
என்ன மாறியதுMarico has scaled its ownership in subsidiary Cosmix Wellness from 60% to 80% via a definitive agreement completed on November 6, 2026.
ஏன் இது முக்கியம்The deal advances Marico's stated strategic goal of scaling its digital-first premium personal care and wellness portfolio, which recently crossed an ARR of Rs 1,000 crore, backed by strong cash reserves.
📅 குறுகிய காலம்Minimal immediate impact on consolidated financials given Cosmix was already a subsidiary, but confirms strong operational execution in scaling D2C brands.
📈 நீண்ட காலம்Enhances long-term exposure to high-growth, digital-first functional wellness and nutrition categories, supporting Marico's margin and premiumization roadmap.
⚠ அபாய எச்சரிக்கைகள்
Related-party transaction (arm's length with existing subsidiary)
Execution and integration risks typical of fast-scaling D2C wellness brands
👀 கவனிக்க வேண்டியவை
Track the growth and margin trajectory of Marico's digital-first food and wellness portfolio in upcoming quarterly earnings to evaluate integration benefits.
Marico Q2 Earnings Call: Revenue Up 13%, PAT Up 31%, Raises FY Profit Guidance to Mid-20s Growth
Marico released the transcript of its Q2 FY27 earnings conference call, detailing a 13% consolidated revenue growth driven by 10% domestic volume growth and 13% international constant currency growth. Gross margin expanded by ~600 bps YoY aided by softer copra prices, pushing EBITDA up 27% and PAT up 31%—its highest profit growth in 50 quarters. The Foods portfolio grew 45% to cross an annualized revenue run rate of ₹1,500 crore. Management raised its full-year profitability guidance to mid-20s growth and expects consolidated revenue to achieve teens growth.
உச்சம் நம்பிக்கை
என்ன மாறியதுSubmission of the formal transcript from the Q2 FY27 earnings call held on November 2, 2026, wherein management upgraded full-year earnings guidance.
ஏன் இது முக்கியம்Confirms strong operating leverage, volume-led domestic recovery (Parachute volume up 13%), and scaling diversification engines (Foods ARR >₹1,500 cr) amid benign input costs.
Consolidated Revenue Growth: 13%Domestic Volume Growth: 10%PAT Growth: 31%EBITDA லாப வரம்பு: 18.2%Foods Annualized Run Rate (ARR): INR 1,500 கோடி
📅 குறுகிய காலம்Market sentiment should remain supported by the upgrade in full-year profit growth guidance to mid-20s and strong volume momentum across core domestic portfolios.
📈 நீண்ட காலம்The structural diversification away from pure coconut hair oils into foods (₹1,500 cr ARR) and digital-first premium personal care, paired with Project SETU distribution expansion, enhances business resilience across commodity cycles.
⚠ அபாய எச்சரிக்கைகள்
Reversal in raw material price cycles (copra and edible oils)
Volume contraction in select rationalized Saffola Edible Oil variants over the next 2-3 quarters
👀 கவனிக்க வேண்டியவை
Monitor raw material trends (copra and edible oils) and track the execution of the Project SETU 2.0 rollout, along with margin delivery in H2 against the upgraded mid-20s profit growth guidance.
Marico Appoints Former HUL MD & CEO Rohit Jawa as Independent Director for 5 Years
Marico's Board of Directors has approved the appointment of Mr. Rohit Jawa as an Additional Director in the capacity of Independent Director. The appointment is for a 5-year tenure effective from January 1, 2027, to December 31, 2031, subject to shareholder approval via postal ballot. Mr. Jawa brings over 38 years of FMCG leadership experience, having previously served as MD & CEO of Hindustan Unilever Limited and President of Unilever South Asia until July 2025.
உச்சம் நம்பிக்கை
என்ன மாறியதுMarico added former HUL MD & CEO Rohit Jawa to its Board as an Independent Director for a 5-year term starting January 1, 2027.
ஏன் இது முக்கியம்Adds high-caliber FMCG leadership experience to the Board, offering strategic insight for Marico's portfolio transformation, premiumisation, and international market expansion.
Tenure: 5 consecutive yearsTerm start date: ஜனவரி 1, 2027Term end date: டிசம்பர் 31, 2031Leadership experience: Over 38 years
📅 குறுகிய காலம்Limited immediate operational or share price impact, as this is an independent board induction scheduled to take effect in January 2027.
📈 நீண்ட காலம்Strengthens corporate governance and provides valuable strategic direction in international scaling and digital-first transformation.
👀 கவனிக்க வேண்டியவை
Track the upcoming postal ballot voting results for formal shareholder approval and observe future strategic guidance, particularly around international expansion and premiumisation.
Marico Reports Q2 Consolidated Revenue Up 13%, PAT Up 31% with 10% India Volume Growth
Marico released its Q2 earnings presentation reporting a 13% YoY growth in consolidated revenue and a 31% YoY surge in consolidated PAT. Operating performance was strong with domestic volume growth of 10% and consolidated EBITDA growing 27% (a 200 bps margin expansion), driven by gross margin expansion of 600 bps. The international business registered 13% constant currency growth (CCG), led by Vietnam (22%) and MENA (15%). Management guided for teens revenue growth crossing ₹15,000 Cr in FY27, targeting ₹20,000+ Cr by FY30 under Vision 2030.
உச்சம் நம்பிக்கை
என்ன மாறியதுMarico shared its Q2 financial update and presentation detailing a 13% revenue growth, 31% PAT expansion, and strategic progress under Project SETU 2.0.
ஏன் இது முக்கியம்Demonstrates strong operational momentum across core brands (Parachute, VAHO) and scaling engines (Foods, Digital-First), reducing reliance on volatile commodity categories.
📅 குறுகிய காலம்Strong operational beat on volumes and profitability is likely to be viewed favorably by the market, highlighting resilience in FMCG demand.
📈 நீண்ட காலம்Strategic focus on premiumization, foods, and digital-first brands aims to lift non-commodity revenue to 50% by FY30, structurally shielding margins.
⚠ அபாய எச்சரிக்கைகள்
Inflation in crude and vegetable oil costs impacting input baskets
Potential demand softness in key international geographies like Bangladesh (5% CCG in Q2)
👀 கவனிக்க வேண்டியவை
Monitor whether the double-digit domestic volume trajectory and margin expansion sustain amid crude and vegetable oil price volatility in H2 FY27.
📊 கடந்த 7 நாட்கள் — உணர்வு அடிப்படையில் பகுப்பாய்வு செய்யப்பட்ட அறிவிப்புகள்
Marico Q2 FY27 Standalone Revenue at ₹3,897 Cr; Ups Plix Stake to 84.09%
Marico reported standalone revenue from operations of ₹3,897 crore for Q2 FY27 (ended September 30, 2026), compared to ₹3,450 crore in Q2 FY26 (restated). The Board also approved the appointment of Independent Director Mr. Rajan Bharti Mittal as Lead Independent Director effective November 2, 2026. Separately, the company announced that on October 5, 2026, it signed an agreement to acquire a further 38.18% stake in Satiya Nutraceuticals (Plix), having already raised its stake to 84.09%, with the remaining 14.09% to be completed in July 2027.
உச்சம் நம்பிக்கை
என்ன மாறியதுMarico reported its Q2 FY27 financial results, appointed a Lead Independent Director, and increased its ownership in digital-first brand Plix to 84.09%.
ஏன் இது முக்கியம்Demonstrates continued top-line growth and reinforces Marico's strategic push to scale its higher-margin digital-first wellness and personal care portfolio.
📅 குறுகிய காலம்Performance shows steady revenue traction YoY; markets will assess volume growth and margins against input cost pressures.
📈 நீண்ட காலம்Consolidation of digital-first brands like Plix and Beardo into Marico supports long-term diversification beyond core coconut oil portfolios.
⚠ அபாய எச்சரிக்கைகள்
Input cost inflation in key raw materials like Copra and vegetable oils
Integration and profitability risks across acquired digital-first subsidiaries
👀 கவனிக்க வேண்டியவை
Track the full consolidated performance and management commentary on volume growth and raw material inflation trends (Copra), alongside the integration timeline of Plix.
Marico acquires additional 24.09% in Plix owner for ₹1,012.03 Cr, stake rises to 84.09%
Marico has entered into definitive agreements to acquire a 38.18% stake in tranches in Satiya Nutraceuticals (owner of 'Plix'), scaling its current stake from 60% to 84.09%. Marico paid an all-cash consideration of ₹1,012.03 Crores for this 24.09% tranche, taking aggregate investment to date to ₹1,392.07 Crores. The target has demonstrated rapid scaling, with consolidated turnover rising from ₹155.32 Crores in FY24 to ₹864.31 Crores in FY26. The final 14.09% stake is slated for acquisition in July 2027 at a base consideration of up to ₹592 Crores plus milestone-linked payouts.
உச்சம் நம்பிக்கை
என்ன மாறியதுMarico increased its controlling stake in subsidiary Satiya Nutraceuticals (brand 'Plix') from 60% to 84.09% through an immediate cash buyout.
ஏன் இது முக்கியம்Plix is an engine in Marico's digital-first and nutrition portfolio, delivering ₹864.31 Cr turnover (~6.3% of Marico's TTM revenue); full consolidation strengthens long-term growth and capital allocation.
Tranche consideration: ₹ 1,012.03 CroresTranche stake acquired: 24.09%Current aggregate stake: 84.09%Plix FY26 turnover: ₹ 864.31 CroresPlix FY26 turnover vs Marico TTM revenue: ~6.35%Tranche cost vs Net worth: ~17.4%
📅 குறுகிய காலம்Substantial cash outlay of ₹1,012.03 Cr will reduce Marico's surplus cash reserves, but reinforces ownership in a fast-growing, high-momentum subsidiary.
📈 நீண்ட காலம்Expands Marico's addressable market in plant-based nutrition and premium wellness, accelerating its strategic shift towards high-growth digital-first brands.
⚠ அபாய எச்சரிக்கைகள்
Valuation sensitivity linked to milestone-based earnouts
Sustaining growth and profitability as Plix scales
👀 கவனிக்க வேண்டியவை
Track the integration and margin profile of Plix in upcoming quarterly disclosures, along with cash balance utilization following the ₹1,012 Cr cash outflow.
Marico released its quarterly update for Q2 FY27, indicating double-digit consolidated revenue growth driven by strong volume momentum. Underlying domestic volume growth reached double digits, led by early-teens volume growth in Parachute Coconut Oil and growth in the twenties for Value Added Hair Oils. Gross margins accelerated year-on-year due to a favorable portfolio mix and copra prices remaining ~35% below peak levels. Operating profit is projected to grow in the mid-twenties, tracking ahead of the company's near-term guidance.
உச்சம் நம்பிக்கை
என்ன மாறியதுMarico issued a pre-earnings operational update for Q2 FY27 reporting robust double-digit volume and revenue growth alongside mid-twenties EBITDA growth expectations.
ஏன் இது முக்கியம்Demonstrates resilience and strong core volume recovery despite volatile macro conditions, supported by lower copra input costs that boost operating profitability.
📅 குறுகிய காலம்Positive sentiment likely leading into the formal Q2 earnings release due to margin expansion and healthy volume growth.
📈 நீண்ட காலம்Structural tailwinds persist as Marico successfully expands higher-margin food and digital-first personal care portfolios alongside core rural penetration.
⚠ அபாய எச்சரிக்கைகள்
Elevated crude-linked derivative input costs
Persistent inflation impacting Bangladesh business
Volume contraction in Saffola Oils
👀 கவனிக்க வேண்டியவை
Track the detailed audited Q2 FY27 financial results release for exact margin prints and management commentary on raw material inflation trends.
23% Revenue Growth: Marico Reports Highest Profit Growth in 28 Quarters in Q1 FY27
Marico delivered a robust Q1 FY27 with consolidated revenue growing 23% and PAT increasing 25% YoY, marking its highest profit growth in seven years. The India business saw a significant volume recovery of 11%, led by Parachute Rigids and a 43% surge in the Foods segment. Management has provided a confident outlook for FY27, targeting revenue to exceed Rs 15,000 Cr (a ~10% increase over TTM levels) and aiming for 20% EBITDA growth. The diversification strategy is gaining scale, with Foods and Digital-first brands now contributing significantly to the top line.
உச்சம் நம்பிக்கை
என்ன மாறியதுMarico has successfully pivoted from low-single-digit volume growth to double-digit (11%) domestic volume growth while scaling new growth engines like Foods and Digital brands.
ஏன் இது முக்கியம்The strong performance validates Marico's diversification strategy, reducing reliance on core coconut oil and moving towards a high-growth, premiumized FMCG portfolio with a Vision 2030 target of Rs 20,000 Cr revenue.
📅 குறுகிய காலம்The stock is likely to react positively to the strong volume beat and the management's upgraded confidence in hitting 20% EBITDA growth for the full year.
📈 நீண்ட காலம்Marico is structurally transforming into a diversified FMCG player; the scaling of Foods and Digital brands (now ~20% of India revenue) provides a long-term growth runway beyond core oils.
⚠ அபாய எச்சரிக்கைகள்
Upward bias in crude and vegetable oil prices impacting Q2 margins
Geopolitical and inflationary pressures in the Bangladesh market
👀 கவனிக்க வேண்டியவை
Investors should monitor the sustainability of double-digit volume growth in the domestic market and the margin impact of rising vegetable oil prices on the Saffola portfolio in Q2.
23% Revenue Growth: Marico Reports Highest PAT Growth in 28 Quarters for Q1 FY27
Marico delivered a robust Q1 FY27 performance with consolidated revenue growing 23% YoY and PAT increasing by 25%, its highest profit growth in 28 quarters. Domestic volume growth reached a 20-quarter high of 11%, significantly outperforming recent trends, led by a 10% volume surge in Parachute Coconut Oil. The company's diversification strategy is gaining traction, with the Foods business growing 43% and the Digital-first portfolio reaching an ARR of over ₹1,100 crore. Management has guided for revenue to exceed ₹15,000 crore in FY27 with high-teen EBITDA growth.
உச்சம் நம்பிக்கை
என்ன மாறியதுMarico has accelerated its domestic volume growth from mid-single digits to 11% while successfully scaling its non-commodity portfolio (Foods and Premium Personal Care).
ஏன் இது முக்கியம்The results validate Marico's strategic shift toward high-margin, non-commodity categories, which now contribute 23% of India revenue, reducing the company's historical dependence on volatile copra prices.
📅 குறுகிய காலம்The stock is likely to react positively to the multi-quarter high volume growth and strong profit beat, reflecting improved execution and market share gains.
📈 நீண்ட காலம்Marico is structurally transforming into a diversified FMCG player with a clear roadmap (Vision 2030) to reach ₹20,000 crore revenue by increasing the share of premium and digital brands.
⚠ அபாய எச்சரிக்கைகள்
High single-digit volume decline in Saffola Edible Oils
Inflationary pressures and transient demand softness in Bangladesh
Volatility in crude-linked input costs
👀 கவனிக்க வேண்டியவை
Monitor the sustainability of double-digit volume growth in the domestic market and the margin expansion of the Digital-first portfolio, which is targeted to reach double-digit EBITDA margins by FY27.
Marico reported a strong start to FY27 with consolidated revenue reaching ₹3,957 crore, a 22.8% increase over the ₹3,221 crore reported in Q1 FY26. Profit Before Tax (PBT) grew 20.4% YoY to ₹790 crore, demonstrating resilient performance despite a significant 47.8% jump in raw material costs. The company also completed the internal restructuring of digital-first brands Beardo and Just Herbs into its standalone operations. A change in accounting policy was implemented to net off certain promotional expenses from revenue, which has no impact on the bottom line.
உச்சம் நம்பிக்கை
என்ன மாறியதுMarico reported its Q1 FY27 financial results and completed the legal integration of its D2C brands Beardo and Just Herbs into the standalone entity.
ஏன் இது முக்கியம்The double-digit revenue growth exceeds the company's long-term 10% target, indicating strong market share gains or successful pricing actions. The integration of D2C brands aims to drive operational synergies and cost efficiencies.
Consolidated Revenue (Q1 FY27): ₹3,957 கோடிRevenue Growth (YoY): 22.8%Profit Before Tax (Q1 FY27): ₹790 கோடிCost of Materials Consumed: ₹1,751 கோடிStandalone Basic EPS: ₹3.55Revenue vs TTM Revenue: 29.07%
📅 குறுகிய காலம்The stock is likely to react positively to the strong top-line and bottom-line growth figures which outperformed the previous year's base.
📈 நீண்ட காலம்Structural shift towards Foods and Digital-first brands is diversifying the revenue base away from core oils, potentially leading to higher valuation multiples over time.
⚠ அபாய எச்சரிக்கைகள்
Significant 47.8% increase in raw material costs could pressure margins if pricing power is tested by competition.
👀 கவனிக்க வேண்டியவை
Investors should monitor the volume growth sustainability in the domestic market and the margin impact of Copra price volatility in the coming quarters. The successful scaling of the integrated Digital-first portfolio (ARR >₹1,000 Cr) remains a key long-term value driver.
Marico Announces ₹4 Final Dividend; 38th AGM Scheduled for August 6, 2026
Marico Limited has scheduled its 38th Annual General Meeting (AGM) for August 6, 2026, and released its Integrated Annual Report for FY 2025-26. The company has declared a final dividend of ₹4 per equity share (face value ₹1), with a record date of July 30, 2026. This dividend follows a year where TTM revenue reached ₹13,611 Cr and PAT stood at ₹1,813 Cr. Shareholders must ensure KYC and bank details are updated by the record date to receive payments by September 5, 2026.
உச்சம் நம்பிக்கை
என்ன மாறியதுMarico has formalized the timeline for its 38th AGM and confirmed the specific dates and amount for the final dividend payout for FY 2025-26.
ஏன் இது முக்கியம்The announcement confirms a cash payout to shareholders and provides the platform (AGM) for management to discuss the strategy for reaching 10%+ growth and scaling the Foods business.
Final Dividend: ₹4 per shareDividend Yield (at ₹852.4): 0.47%ரெக்கார்ட் தேதி: ஜூலை 30, 2026AGM Date: ஆகஸ்ட் 6, 2026Payment Date: செப்டம்பர் 5, 2026
📅 குறுகிய காலம்The stock may experience minor price adjustments around the ex-dividend date near July 30, 2026.
📈 நீண்ட காலம்Limited structural impact as this is a routine annual corporate action, though the annual report will detail the progress of the ₹1,000 Cr ARR Digital-first portfolio.
👀 கவனிக்க வேண்டியவை
Investors should monitor the record date of July 30, 2026, for dividend eligibility and review the Integrated Annual Report for updates on the Digital-first portfolio's growth.
20%+ Revenue Growth Expected in Q1 FY27; India Volume Growth Hits Multi-Quarter High
Marico expects consolidated revenue to grow in the early 20s (%) for Q1 FY27, driven by double-digit underlying volume growth in the India business. Parachute Coconut Oil achieved its highest volume growth in several quarters, while Value Added Hair Oils saw revenue growth in the 20s (%). Despite rising costs in vegetable oils and crude derivatives, a ~45% correction in Copra prices from peak levels is expected to improve gross margins sequentially. International markets grew in the mid-teens, although Bangladesh faced transient demand softness.
உச்சம் நம்பிக்கை
என்ன மாறியதுMarico has transitioned from moderate growth to high-volume growth in its core India portfolio, with revenue growth accelerating to the 20% range compared to previous quarters.
ஏன் இது முக்கியம்The acceleration in volume growth for Parachute and the 20%+ growth in VAHO indicate strong market share gains and successful execution of the diversification strategy into Foods and Premium Personal Care.
Expected Revenue Growth: Early 20s (%)India Volume Growth: Double-digitCopra Price Correction: ~45% from peakVAHO Revenue Growth: 20s (%)International CC Growth: Mid-teens (%)TTM வருவாய்: ₹13,611 கோடி
📅 குறுகிய காலம்The stock is likely to react positively to the guidance of double-digit volume growth and sequential margin improvement, signaling a strong start to FY27.
📈 நீண்ட காலம்The company's focus on Project SETU for direct reach and the scaling of Digital-first brands (already at ₹1,000 Cr+ ARR) provides a structural growth runway beyond traditional oils.
⚠ அபாய எச்சரிக்கைகள்
Sharp rise in vegetable oil and crude-linked derivative costs
Potential impact of El Niño on monsoon and rural consumption
Transient demand softness in the Bangladesh market
👀 கவனிக்க வேண்டியவை
Monitor the upcoming detailed Q1 FY27 financial results to see if the early 20s revenue growth translates into significant PAT growth, considering the 'substantially accelerated' brand-building investments. Watch for the impact of El Niño on rural demand and monsoon progress as a key risk factor for the rest of the year.
Marico Shareholders Approve Girish Paranjpe as Independent Director with 98.86% Majority
Marico Limited has successfully passed a special resolution for the appointment of Mr. Girish Paranjpe as an Independent Director, effective June 1, 2026. The postal ballot saw significant shareholder participation, with 90.38% of the total 129.83 crore shares being polled. The resolution received overwhelming support, with 98.86% of the votes cast in favor and only 1.14% against. This high approval rating from both institutional and retail investors indicates strong confidence in the company's governance and board selection.
முக்கிய அம்சங்கள்
Special resolution passed with 98.86% of total votes cast in favor of the appointment.Total voter turnout was high at 90.38%, representing 117.34 crore shares out of 129.83 crore.Institutional investors showed strong support with 96.73% of their 40.69 crore polled votes in favor.Promoter and Promoter Group voted 100% in favor, accounting for 76.49 crore shares.The appointment is effective from June 1, 2026, following the conclusion of the e-voting process on June 13, 2026.
👀 கவனிக்க வேண்டியவை
Investors should view this as a positive sign of corporate governance and shareholder alignment. No immediate action is required as this is a routine board strengthening measure backed by a strong institutional mandate.
Marico Enters ₹10,000+ Crore Shampoo Market with Parachute Advansed Protein Shampoo
Marico has announced its entry into the hair cleansing segment, targeting India's ₹10,000+ crore shampoo market which is growing at 9-10% annually. This represents the company's most significant category extension in recent years, leveraging the strong brand equity of Parachute Advansed. The product range includes eight variants across multiple price points, including a Re. 1 sachet to drive mass-market penetration. This strategic move aims to capture a larger share of the total hair-care spend and accelerate premiumization within Marico's core portfolio.
முக்கிய அம்சங்கள்
Entry into the ₹10,000+ crore Indian shampoo market growing at 9-10% CAGRLaunch of Parachute Advansed Protein Shampoo with 8 variants and sizes from Re. 1 sachets to 1.2L bottlesStrategic expansion to capture a higher share of the total hair-care regimen beyond traditional hair oilsLeverages existing distribution network across general trade, modern trade, and e-commerceMarico recorded a turnover of ₹136.1 billion (USD 1.5 billion) in FY25-26
👀 கவனிக்க வேண்டியவை
Investors should monitor Marico's ability to gain market share in the competitive shampoo segment, as success here could significantly improve margins and revenue growth. This expansion into high-value adjacencies is a positive indicator of the company's innovation-led growth strategy.
Marico Targets ₹15,000 Cr Revenue in FY27; Foods & Digital Brands Scale Rapidly
Marico reported a strong FY26 with consolidated revenue reaching multi-year highs and the Foods business crossing the ₹1,000 crore revenue mark. The company has set ambitious targets to reach ₹15,000 crores in revenue by FY27 and ₹20,000 crores by FY30, driven by diversification into premium personal care and digital-first brands. Management expects high single-digit volume growth in India and mid-teen constant currency growth in international markets for the upcoming year. Despite geopolitical volatility, the company aims for high-teen EBITDA growth supported by a 35% correction in copra prices from peak levels.
முக்கிய அம்சங்கள்
Targeting ₹15,000 Cr revenue in FY27 and ₹20,000 Cr by FY30 with mid-teen EBITDA growth aspirations.Foods portfolio exited FY26 at ₹1,000+ Cr; Digital-first brands reached an ARR of ₹1,100+ Cr.Bangladesh business witnessed a sharp 35% sales growth in Q4 FY26.Aims to increase the revenue share of Foods and Premium Personal Care to 27% in FY27 and 33% by FY30.Copra prices have corrected by approximately 35% from peaks, providing a margin tailwind.
👀 கவனிக்க வேண்டியவை
Investors should look for sustained execution in the Foods and Digital-first segments as Marico reduces its dependence on commodity-linked categories. The stock is well-positioned to benefit from rural recovery and premiumization trends.
Marico Recommends ₹4.00 Final Dividend for FY26; Sets July 30 as Record Date
Marico's Board has recommended a final equity dividend of ₹4.00 per share for the financial year 2025-26. The record date to determine shareholder eligibility is fixed for July 30, 2026, with payment expected by September 5, 2026. This recommendation is subject to shareholder approval at the upcoming 38th Annual General Meeting on August 6, 2026. The company also approved its audited financial results for FY26, with major subsidiaries contributing ₹4,972 crores in revenue.
முக்கிய அம்சங்கள்
Recommended final dividend of ₹4.00 per equity share of face value ₹1 each for FY26Record date for dividend entitlement is set for Thursday, July 30, 2026Dividend payment to be completed on or before September 5, 2026, post-AGM approvalAudited consolidated revenue from 11 major subsidiaries stood at ₹4,972 crores for the fiscal yearThe 38th Annual General Meeting (AGM) is scheduled for August 6, 2026
👀 கவனிக்க வேண்டியவை
Investors interested in the dividend payout should ensure they hold the stock before the July 30 record date. The consistent dividend policy reinforces Marico's status as a stable cash-generating FMCG play.
Marico Appoints Former Wipro Joint-CEO Girish Paranjpe as Independent Director for 5-Year Term
Marico Limited has appointed Mr. Girish Paranjpe as an Independent Director for a five-year term effective June 1, 2026. Mr. Paranjpe brings over 35 years of corporate experience, notably having served as the Joint-CEO of Wipro's IT business, which was valued at USD 5.8 billion during his tenure. He currently holds significant leadership roles, including Chairman of Mphasis and Independent Director at Axis Bank and Crisil. The appointment is subject to shareholder approval via a postal ballot process.
முக்கிய அம்சங்கள்
Appointment of Mr. Girish Paranjpe as Independent Director for a 5-year term until May 31, 2031.Mr. Paranjpe previously managed Wipro's IT business with USD 5.8 billion in revenue and 100,000+ employees.He currently serves as Non-Executive Independent Chairman of Mphasis Limited and Director at Axis Bank and Crisil.The board is seeking shareholder approval for the appointment through a postal ballot process.
👀 கவனிக்க வேண்டியவை
This is a positive corporate governance development; investors should welcome the addition of a highly experienced leader to the board. No immediate action is required as this is a routine high-level management update.
Marico Q4 FY26: Revenue Jumps 22%, India Volumes Up 9%, Foods Business Crosses ₹1,000 Cr Mark
Marico reported a strong performance for FY26, with consolidated revenue growing 26% YoY to ₹13,611 Cr and recurring PAT rising 11%. The India business demonstrated robust volume growth of 9% in Q4, driven by Value Added Hair Oils and the Foods segment, which achieved a milestone of ₹1,000+ Cr in annual revenue. While EBITDA margins contracted to 15.6% in Q4 due to a 57% YoY surge in copra prices, the International business maintained high momentum with 20% constant currency growth for the full year. Management has provided an optimistic outlook, aiming to cross ₹15,000 Cr in revenue by FY27.
முக்கிய அம்சங்கள்
Consolidated revenue for FY26 grew 26% to ₹13,611 Cr, with Q4 revenue increasing 22% YoY to ₹3,333 Cr.India business recorded 9% volume growth in Q4, while International business delivered 19% constant currency growth.Foods business crossed the ₹1,000 Cr mark in FY26, and Digital-first brands reached an exit ARR of ₹1,100+ Cr.EBITDA margins for FY26 stood at 17.1% compared to 19.7% in FY25, impacted by significant inflation in copra and other input costs.Management targets a double-digit revenue CAGR to reach ₹20,000+ Cr by FY30, focusing on premiumization and diversification.
👀 கவனிக்க வேண்டியவை
Investors should view the strong volume recovery and successful scaling of the Foods and Digital-first portfolios as key long-term value drivers. While raw material inflation (Copra) may pressure margins in the short term, the company's guidance for high-teen EBITDA growth in FY27 suggests confidence in pricing power and cost management.
Marico Completes 75% Acquisition of Vietnam-based Skinetiq Joint Stock Company
Marico Limited, through its subsidiary Marico South East Asia Corporation (MSEA), has successfully completed the acquisition of a 75% stake in Skinetiq Joint Stock Company. Based in Vietnam, Skinetiq owns the digital-first skincare brand 'Candid' and holds exclusive distribution rights for the premium brand 'Murad'. This acquisition, finalized on April 2, 2026, marks a significant step in Marico's strategy to expand its international beauty and personal care footprint. The move is expected to strengthen Marico's presence in the high-growth Southeast Asian skincare market.
முக்கிய அம்சங்கள்
Acquisition of 75% total share capital of Skinetiq Joint Stock Company completed on April 2, 2026Skinetiq owns 'Candid', a digital-first skincare brand in the Vietnamese marketTarget company holds exclusive distribution rights for the premium brand 'Murad' in VietnamSkinetiq has officially become a subsidiary of Marico Limited following the transaction closure
👀 கவனிக்க வேண்டியவை
Investors should monitor the integration of Skinetiq into Marico's international portfolio and its impact on consolidated margins. This expansion into premium skincare categories in Vietnam provides a long-term growth lever for the company's international business.
⚠️இந்தத் தளம் எவ்வாறு உருவாக்கப்படுகிறது: சந்தைத் தரவுப் பக்கங்கள் NSE/BSE வெளியீடுகள் மற்றும் நிறுவனங்களின் தாக்கல்களிலிருந்து தானாகக் கணக்கிடப்படுகின்றன; செய்திக் கட்டுரைகளும் அறிவிப்புப் பகுப்பாய்வுகளும் AI உதவியுடன் எழுதப்படுகின்றன, மனித மேற்பார்வையுடன்: AI உருவாக்குவதை எங்கள் ஆசிரியர்கள் மதிப்பாய்வு செய்கின்றனர். இரண்டிலும் பிழைகள் இருக்கலாம். எந்தவொரு முதலீட்டு முடிவுக்கு முன்பும் அசல் மூலங்களில் சரிபார்க்கவும். முதலீட்டு ஆலோசனை அல்ல; Flash Finance SEBI-பதிவு பெற்றது அல்ல. நாங்கள் AI-ஐ எவ்வாறு பயன்படுத்துகிறோம்
🎁 ஆரம்பகால ஆதரவாளர்களுக்கு மட்டும் · குறுகிய கால சலுகை
எங்கள் AI பங்குச் சந்தை பகுப்பாய்வு: டெலிகிராம், வாட்ஸ்அப்பில் இலவசம்
⚡ 3500+ நிறுவனங்களை நாங்கள் உடனுக்குடன் கண்காணிக்கிறோம். NSE-யில் ஒரு நிறுவன அறிவிப்பு வெளியானதுமே, எங்கள் AI அதைப் படித்து, சுருக்கி, அதன் தாக்கத்தைச் சில நொடிகளில் உங்களுக்குச் சொல்கிறது.
இதுபோன்ற AI பகுப்பாய்வுக்குக் கட்டணத் தளங்கள் ஆண்டுக்கு ₹1,00,000-க்கும் மேல் வசூலிக்கின்றன. எங்கள் சேனல்களில் இது இலவசம்.
